Active	Status	Sponsor type	Region	Phase	Filter
5 Active 7 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Werth, Victoria
AMETHYST, NCT05531565 / 2020-000727-40: A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus	Recruiting	2/3	474	Europe, Canada, Japan, US, RoW	Litifilimab, BIIB059, Placebo	Biogen, Biogen Idec Research Limited	Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus	10/26	12/27
RECAST DLE, NCT05591222 / 2022-000831-21: Study of Daxdilimab (HZN-7734) in Patients With Moderate-to-Severe Primary Discoid Lupus Erythematosus	Active, not recruiting	2	72	Europe, Canada, US, RoW	Placebo/Daxdilimab, Daxdilimab, HZN-7734	Amgen, Horizon Therapeutics Ireland DAC	Discoid Lupus Erythematosus	09/25	09/25
NCT01510067: Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus	Recruiting	N/A	700	US		University of Pennsylvania	Cutaneous Lupus Erythematosus (CLE)	01/25	01/25
NCT02945345: Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)	Recruiting	N/A	300	US		University of Pennsylvania	Dermatomyositis	01/25	01/25
AIBD, NCT02753777: Autoimmune Blistering Diseases Study	Recruiting	N/A	150	US	Questionnaires	University of Pennsylvania	Pemphigus Vulgaris, Pemphigus Foliaceus, Bullous Pemphigoid	01/25	01/25